BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Synthetech (NZYM) Release: Designates {1} As 2003 Raw Materials Vendor Of The Year


10/19/2005 5:10:56 PM

ALBANY, Ore., April 15 /PRNewswire-FirstCall/ -- Synthetech, Inc. announced today that Roche Colorado Corporation (RCC) has recognized the Company with its Vendor of the Year Award for Raw Materials for 2003. The award cites Synthetech as a most valued supplier to Roche for nearly two decades, with special mention of Synthetech's overall superior performance as a bulk supplier of over a dozen Peptide Building Blocks (PBBs) for two marketed drugs -- Nafarelin(R) and Fuzeon(R). In a letter accompanying this prestigious award, Theresa Sinner, RCC's Materials and Purchasing Manager, praised the Company's product quality and "large amounts" of customer service, and characterized Synthetech as a "World Class Partner" and a supplier Roche can "always count on."

  Key selection criteria used by RCC for this annual award include:

  -- Supply of the highest quality on a consistent basis;
  -- Timely delivery, with zero unscheduled interruptions;
  -- Competitive pricing with a continued desire to lower costs while
     improving processes; and
  -- Total business impact the supplier has had for RCC

Accepting the award on behalf of the Synthetech team, M. "Sreeni" Sreenivasan, President & CEO, said, "It is a pleasant surprise to be honored by a leading multinational pharmaceutical company like Roche. Our relentless focus on customer service and the dedication of our associates have earned us this enviable recognition. In addition to providing competitive pricing on a global basis, we strive to consistently provide the highest levels of quality, responsiveness and reliability."

About Synthetech

Synthetech's products are used predominantly by pharmaceutical and biotech companies to make a wide range of peptide, peptidomimetic small molecule and other drugs under development or on the market for the treatment of AIDS, cancer, cardiovascular and other diseases. The Company has established a worldwide reputation in a unique product and technology niche as a leading supplier to the pharmaceutical and life sciences industry.

About Roche Colorado (RCC)

RCC is one of four U.S.-based operating units of F. Hoffmann - La Roche, Switzerland. RCC manufactures bulk pharmaceutical intermediates and active ingredients for prescription and over-the-counter medicines. The compounds that RCC produces are sent to other manufacturing sites for formulation into finished pharmaceutical products.

More Information: Web site: http:/www.synthetech.com , E-mail: investor@synthetech.com M. "Sreeni" Sreenivasan, President & CEO 541-967-6575 Gary Weber, CFO 541-967-6575

Synthetech, Inc.

CONTACT: M. "Sreeni" Sreenivasan, President & CEO, +1-541-967-6575, orGary Weber, CFO, +1-541-967-6575, both of Synthetech, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES